Nuvation Bio (NUVB) Return on Assets Growth (1y): 2021-2025
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Summit Therapeutics Inc. | 1,387.71B | 1,387.50B | - | - |
| 2 | BeOne Medicines Ltd. | 458.68B | 457.16B | 1.15B | - |
| 3 | Vertex Pharmaceuticals Inc / Ma | 102.37B | 99.35B | - | - |
| 4 | Benitec Biopharma Inc. | 65.38B | 65.31B | - | - |
| 5 | Regeneron Pharmaceuticals, Inc. | 60.67B | 60.28B | - | - |
| 6 | Alnylam Pharmaceuticals, Inc. | 60.53B | 62.66B | - | - |
| 7 | Argenx Se | 45.96B | 50.00B | - | - |
| 8 | INSMED Inc | 26.50B | 27.40B | - | - |
| 9 | BioNTech SE | 25.15B | 17.24B | - | - |
| 10 | Nuvation Bio Inc. | 1.42B | 1.38B | 2.26M | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 56 |
| Jun 30, 2025 | 49 |
| Mar 31, 2025 | -106 |
| Dec 31, 2024 | -90 |
| Sep 30, 2024 | -78 |
| Jun 30, 2024 | -71 |
| Mar 31, 2024 | 5 |
| Dec 31, 2023 | 3 |
| Sep 30, 2023 | 2 |
| Jun 30, 2023 | 0 |
| Mar 31, 2023 | -4 |
| Dec 31, 2022 | -4 |